Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway

Journal of Neuroscience

Volumn 19, Issue 11, 1999, Pages 4682-4694

  Rodríguez, Manuel ^a   González Hernández, Tomás ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Calbindin D28k; Calretinin; Cholecystokinin; Dopaminergic cells; GABA; GABAergic cells; Glutamic acid decarboxylase; Nigrostriatal pathway; Parkinson's disease; Parvalbumin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALRETININ; CHOLECYSTOKININ; GLUTAMATE DECARBOXYLASE; HORSERADISH PEROXIDASE; OXIDOPAMINE; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MALE; MORPHOLOGY; NERVE CELL DEGENERATION; NEUROCHEMISTRY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0345711494     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-11-04682.1999     Document Type: Article

References (105)

1. Adams JC (1977) Technical considerations on the use of horseradish peroxidase as a neuronal marker. Neuroscience 2:141-145.
2. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29:775.
3. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
4. Alexander GE, Crutcher MD (1990a) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271.
5. Alexander GE, Crutcher MD (1990b) Preparation for movement: neural representations of intended direction in three motor areas of the monkey. J Neurophysiol 68:945-960.
6. Alexander GE, DeLong MP, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurobiol 9:357-381.
7. Arbuthnott GW (1974) Spontaneous activity of spontaneous units in the striatum after unilateral destruction of the dopamine input. J Physiol (Lond) 239:121-122.
8. Barroso N, Rodriguez M (1996) Action of β-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission. Eur J Pharmacol 297:195-203.
9. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, Walters J, Levey AI, Greenamyre JT (1997) Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17:6761-6768.
10. Burbaud P, Gross C, Benazzouz A, Coussemacq M, Bioulac B (1995) Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp Brain Res 105:48-58.
11. Burunat E, Castro R, Diaz-Palarea MD, Rodriguez M (1988) Conditioning of the early behavioral response to apomorphine in the rotational model of Parkinson's disease. Eur J Pharmacol 145:323-328.
12. Campbell KJ, Takada M, Hattori T (1991) Co-localization of tyrosine hydroxylase and glutamate decarboxylase in a subpopulation of single nigrotectal projection neurons. Brain Res 558:239-244.
13. Castellano MA, Rodriguez M (1991) Nigrostriatal dopaminergic cell activity is under control by substantia nigra of the contralateral brain side: electrophysiological evidence. Brain Res Bull 1991:27:213-218.
14. Castellano MA, Rivero FL, Rodriguez M (1993) Spontaneous firing of nigrostriatal dopaminergic neurons in split-brain rats. Neurose Lett 162:1-4.
15. Castro R, Abreu P, Calzadilla CH, Rodriguez M (1985) Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage intervals. Psychopharmacology 85:333-339.
16. Charara A, Parent A (1984) Brainstem dopaminergic, cholinergic and serotonergic afferents to the pallidum in the squirrel monkey. Brain Res 640:155-170.
17. Chesslet MF, Delfs JM (1996) Basal ganglia and movement disorders: an update. Trends Neurosci 19:417-422.
18. Childs J, Gale K (1983) Neurochemical evidence for a nigrotegmental GABAergic projection. Brain Res 258:109-114.
19. Chiodo LA (1988) Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci Biobehav Rev 12:49-91.
20. Ciliax BJ, Heilman C, Demchyshysn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
21. Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical and hydroxyradical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J Biol Chem 249:2447-2452.
22. Condé H (1992) Organization and physiology of the substantia nigra. Exp Brain Res 88:233-248.
23. Dahlström A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. demonstration of monoamines in the central nervous system. Acta Physiol Scand [Suppl] 62:232.
24. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
25. DeLong MR, Georgopoulos AP (1979) Motor functions of basal ganglia as revealed by studies of single cell activity in the behaving primate. Adv Neurol 24:131-140.
26. DeLong MR, Crutcher MD, Georgopoulos AP (1983) Relations between movement and single cell discharge in the substantia nigra of the behaving monkey. J Neurosci 3:1599-1606.
27. Deniau JM, Chevalier G (1992) The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons. Neuroscience 46:361-377.
28. Deniau JM, Thierry (1997) Anatomical segregation of information processing in the rat substantia nigra pars reticulata. In: Advances in neurology, Vol 74, The basal ganglia and new surgical approaches for Parkinson's disease (Obeso JA, Delong MR, Ohye C, Marsden CD, eds), pp 83-96. Philadelphia: Lippincott-Raven.
29. Deniau JM, Hammond C, Riszk A, Feger J (1978) Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidences for the existence of branched neurons. Exp Brain Res 32:409-422.
30. Eggermont JJ (1990) The correlative brain. Berlin: Springer.
31. Ehringer H, Hornykiewicz O (1960) Verteilung von noradrenalin und dopamin (3-hydroxy-tyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin Wochenschr 38:1236-1239.
32. Fallon JH, Moore RY (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545-580.
33. Fallon JH, Hicks BR, Loughlin SE (1983) The origin of cholecystokinin terminals in the basal forebrain of the rat: evidence from immunofluorescence and retrograde tracing. Neurosci Lett 37:29-35.
34. Freeman AS, Chiodo LA (1988) Multiple effects of cholecystokinin octapeptide on identified nigrostriatal dopaminergic neurons. Brain Res 439:266-274.
35. Garcia P, Paz C, Rodríguez J, Rodríguez M (1998) Unsupervised classification of neural spikes with a hybrid multilayer artificial neural network. J Neurosci Methods 82:59-73.
36. Gerfen CR (1985) The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. J Comp Neurol 236:454-476.
37. Gerfen CR, Herkenham M, Thibault J (1987) The neostriatal mosaic: II. Patch-and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915-3934.
38. Gerfen CR, Engber TR, Mahan LC, Suzel Z, Chase TN, Monsma FR, Sibbley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990:1429-1432.
39. Georgopoulos AP, DeLong MR, Crutcher MD (1983) Relations between parameters of step-tracking movements and single cell discharge in the globus pallidus and subthalamic nucleus of the behaving monkey. J Neurosci 3:1586-1598.
40. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28.
41. Gonon FG (1997) Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 17:5972-5978.
42. Gonon FG, Buda MJ (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltametry in the rat striatum. Neuroscience 14:765-774.
43. Goodman M, Perchére JF, Haiech J, Demaille JG (1979) Evolutionary diversification of structure and function in the family of intracellular calcium-binding proteins. J Mol Evol 13:331-352.
44. Grace AA, Bunney BS (1980) Nigral dopamine neurons: intracellular recording and identification with L-DOPA injection and histofluorescence. Science 210:645-656.
45. Grace AA, Bunney BS (1983a) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10:301-315.
46. Grace AA, Bunney BS (1983b) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-2. Action potential generating mechanisms and morphological correlates. Neuroscience 10:317-331.
47. Grace AA, Bunney BS (1983c) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-3. Evidence of electrotonic coupling. Neuroscience 10:333-348.
48. Grace AA, Bunney BS (1984a) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4:2866-2876.
49. Grace AA, Bunney BS (1984b) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
50. Grace AA, Bunney BS (1985a) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333:271-284.
51. Grace AA, Bunney BS (1985b) Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res 333:285-298.
52. Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
53. Guyenet PG, Aghajanian GK (1978) Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res 150:69-84.
54. Hedreen JC, DeLong MR (1991) Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 304:569-595.
55. Heizmann CW, Hunziker W (1991) Intracellular calcium-binding proteins: more sites than insights. Trends Mol Sci 16:98-103.
56. Herrero MT, Ruberg M, Hirsch EC, Movatt A, Obeso JA, Agid Y, Javoy-Agid F (1993) In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci Lett 157:57-61.
57. Hikosaka O, Wurtz RH (1983a) Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of visual and auditory responses to saccades. J Neurophysiol 49:1230-1253.
58. Hikosaka O, Wurtz RH (1983b) Visual and oculomotor functions of monkey substantia nigra pars reticulata. II. Visual responses related to fixation of gaze. J Neurophysiol 49:1254-1267.
59. Hikosaka O, Wurtz RH (1983c) Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses. J Neurophysiol 49:1268-1284.
60. Houssain MA, Weiner N (1995) Interactions of dopamienrgic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. J Pharmacol Exp Ther 275:237-244.
61. Hökfelt T, Ungerstedt U (1973) Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res 60:269-297.
62. Hökfelt T, Rehfeld JF, Skirboll L, Iremark B, Goldstein M, Markey K (1980) Evidence for coexistence of dopamine and cholecystokinin in the mesolimbic neurons. Nature 285:476-478.
63. Hökfelt T, Skirboll L, Everitt B, Meister B, Brownstein M, Jacobs M, Faden S, Kuga S, Goldstein M, Markstein R, Dockray G, Rehfeld J (1985) Distribution of cholecystokinin-like immunoreactivity in the nervous system: co-existence with classical neurotransmitter and other neuropeptides. Ann NY Acad Sci 448:255-274.
64. Jacopino AM, Quintero EM, Miller EK (1994) Calbindin-D28k: a potential neuroprotective protein. Neurodegeneration 3:1-20.
65. Joseph JP, Boussaoud D (1985) Role of the cat substantia nigra pars reticulata in eye and head movements I. Neural activity. Exp Brain Res 57:286-296.
66. Kilpatrick IC, Starr MS, Fletchar A, James TA, MacLeod NK (1980) Evidence for a GABAergic nigrothalamic pathway in the rat. Exp Brain Res 40:45-54.
67. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
68. Lewis DA, Sesack SR (1997) Dopamine systems in the primate brain. In: Handbook of chemical neuroanatomy, Vol 13, The primate nervous system, Pt I (Bloom FE, Björklund A, Hökfelt T, eds), pp 263-375. Amsterdam: Elsevier.
69. Liang CL, Sinton CM, German DC (1996) Midbrain dopaminergic neurons in the mouse: co-localization with calbindin-D28k and calrretinin. Neuroscience 75:523-533.
70. MacLeod NK, Ryman A, Arbuthnott GW (1990) Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience 38:447-456.
71. Marsden CD, Linazasoro G, Obeso JA (1997) An introduction to the new surgery for Parkinson's disease: past and present problems. In: Advances in neurology, Vol 74, The basal ganglia and new surgical approaches for Parkinson's disease (Obeso JA, DeLong MR, Ohye C, Marsden CD, eds), pp 143-148. New York: Lippincott-Raven.
72. McRitchie DA, Hardman CD, Halliday GM (1996) Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364:121-150.
73. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI (1997) Immunocytochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 41:530-539,
74. Obeso JA, Rodríguez MC, DeLong MR (1997) Basal ganglia pathophysiology: a critical review. In: Advances in neurology, Vol 74, The basal ganglia and new surgical approaches for Parkinson's disease (Obeso JA, DeLong MR, Ohye C, Marsden CD, eds), pp 3-18. New York: Lippincott-Raven.
75. Overton PG, Clark D (1997) Burst firing in midbrain dopaminergic neurons. Brain Res Rev 25:312-334.
76. Parent A, Ciccheti F (1998) The current model of basal ganglia organi-zation under scrutiny. Mov Disord 13:199-202.
77. Parent A, Hazrati L-N (1995) Functional anatomy of the basal ganglia. I. The cortico-basall ganglia-thalamo-cortical loop. Brain Res Rev 20:91-127.
78. Parent A, Mackey A, De Bellefeuille L (1983) The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience 10:1137-1150.
79. Paxinos G, Watson C (1988) The rat brain in stereotaxic coordinates. New York: Academic.
80. Penney JB, Young AB (1983) Speculation on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci 6:73-94.
81. Pollak P, Benabid A-L, Limousin P, Benazzouz A (1997) Chronic intracerebral stimulation in Parkinson's disease. In: Advances in neurology, Vol 74, The basal ganglia and new surgical approaches for Parkinson's disease (Obeso JA, DeLong MR, Ohye C, Marsden CD, eds), pp 113-120. New York: Lippincott-Raven.
82. Rajakumar N, Elisevich K, Flumerfelt BA (1994) Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat. J Comp Neurol 350:324-336.
83. Reiner A, Anderson KD (1993) Co-occurrence of gamma-aminobutyric acid, parvalbumin and the neurotensin-related neuropeptide LANT6 in pallidal, nigral and striatal neurons in pigeons and monkeys. Brain Res 624:317-325.
84. Résibois A, Rogers JH (1992) Calretinin in the rat brain: an immunohistochemical study. Neuroscience 46:101-134.
85. Robledo P, Féger J (1992) Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. J Neural Transm Gen Sect 86:115-126.
86. Rodriguez M, Barroso N (1996) Beta-phenylethylamine regulation of dopaminergic nigrostriatal cell activity. Brain Res 703:201-204.
87. Rogers JH (1987) A gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105:1343-1353.
88. Ruffieux A, Schultz W (1980) Dopaminergic activation of reticulata neurons in the substantia nigra. Nature 285:240-241.
89. Samuel D, Kumar U, Niequllon A (1988) Gamma-aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two models of regulation? J Neurochem 51:1704-1710.
90. Sanderson P, Mavoungou R, Elbe-Fessard D (1986) Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta. Neurosci Lett 67:25-30.
91. Schultz (1986) Activity of pars reticulata neurons of monkey substantia nigra in relation to motor, sensory, and complex events. J Neurophysiol 55:660-677.
92. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80:1-27.
93. Schultz W, Romo R (1990) Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J Neurophysiol 63:607-624.
94. Schultz W, Ruffieux A, Aebischer P (1983) The activity of pars compacta neurons of the monkey substantia nigra in relation to motor activation. Exp Brain Res 51:377-387.
95. Schwarz M, Sontag KH, Wand P (1984) Sensory-motor processing in substantia nigra pars reticulata in conscious cats. J Physiol (Lond) 347:129-147.
96. Seroogy KB, Dangaran K, Lim S, Haycock JW, Fallon JH (1989) Ventral mesencephalic neurons containing both cholecystokinin-and tyronine hydroxylase-like immunoreactivities project to forebrain regions. J Comp Neurol 279:397-414.
97. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ (1998) Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 18:8003-8015.
98. Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321-353.
99. Tanaka Y, Niijima K, Mizuno Y, Yoshida M (1986) Changes in GABA, glutamate, glycine and taurine contents in the striatum after unilateral nigrostriatal lesion in rats. Exp Neurol 91:259-268.
100. van der Kooy D, Coscina DV, Hattori T (1981) Is there a non-dopaminergic nigrostriatal pathway? Neuroscience 6:345-357.
101. Vila M, Herrero MT, Levy R, Faucheux B, Ruberg M, Guillen J, Luquin MR, Guridi J, Javoy-Agid F, Agid Y, Obeso JA, Hirsch EC (1996) Consequences of nigrostriatal denervation on the gamma-aminobutyric acid neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46:802-809.
102. Viteck JL, Bakay AE, DeLong MR (1997) Microelectrode-guided pallidotomy for medically intractable Parkinson's disease. In: Advances in neurology, Vol 74, The basal ganglia and new surgical approaches for Parkinson's disease (Obeso JA, DeLong MR, Ohye C, Marsden CD, eds), pp 183-198. New York: Lippincott-Raven.
103. Walkinshaw G, Waters CM (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63:975-987.
104. Wichmann T, DeLong MR (1996) Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6:751-758.
105. Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28k. Brain Res 526:303-307.